Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun 15;3(2):260-262.
doi: 10.1016/j.jaccao.2021.04.004. eCollection 2021 Jun.

Post-Transplantation Cyclophosphamide: An Old Nemesis to a New Transplant Paradigm?

Seth J Rotz  1   2 , Patrick Collier  3 , Betty K Hamilton  2
Affiliations
Editorial

Post-Transplantation Cyclophosphamide: An Old Nemesis to a New Transplant Paradigm?

Seth J Rotz et al. JACC CardioOncol. .
No abstract available

Keywords: PT-Cy; cardiomyopathy; cardiotoxicity; cyclophosphamide; heart failure; hematopoietic cell transplantation.

PubMed Disclaimer

Conflict of interest statement

This work was supported in part by a grant from the National Institutes of Health National Center for Advancing Translational Sciences (2KL2TR002547 to Dr. Rotz). All authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jaccao.2021.02.011

References

    1. Appelbaum F., Strauchen J.A., Graw R.G., Jr. Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet. 1976;1:58–62. - PubMed
    1. Buja L.M., Ferrans V.J., Graw R.G., Jr. Cardiac pathologic findings in patients treated with bone marrow transplantation. Hum Pathol. 1976;7:17–45. - PubMed
    1. Goldberg M.A., Antin J.H., Guinan E.C., Rappeport J.M. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 1986;68:1114–1118. - PubMed
    1. Braverman A.C., Antin J.H., Plappert M.T., Cook E.F., Lee R.T. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991;9:1215–1223. - PubMed
    1. McCurdy S.R., Luznik L. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide. Hematology. 2019;2019:513–521. - PMC - PubMed

Publication types

LinkOut - more resources